Skip to main content
Trigyn Wins Rules Based Open Source Development Project for Life Sciences

Trigyn Wins Rules Based Open Source Development Project for Life Sciences

Trigyn announced today that it has entered into an agreement with a multi billion dollar international Life Sciences Company to develop a state-of-the-art, rules based open source system. The system will be designed to provide the client's sales force with a unified tool to increase productivity and sales. At the heart of the system will be a rules based engine which will enable the system to scale and provide a high degree of flexibility without the need for extensive and costly future programming changes. The system will be rolled out in the US, European and Asian marketplaces. Trigyn was awarded the contract following the successful delivery of the System Requirements Specifications, High Level Design Documentation and a functioning Prototype using the selected technologies. Tom Gordon, Senior Vice President commented that “this award demonstrates the confidence that our client has developed in Trigyn's ability to understand the complex nature of their application, execute on all aspects of the requirements gathering and design phases, and delivering a functioning Prototype that met the client's needs".

Recent News

Launch of e-Migrate Portal and App will Streamline Overseas Employment

Launch of e-Migrate Portal and App will Streamline Overseas Employment

Launch of e-Migrate Portal and App will Streamline Overseas Employment

Trigyn Announces AI Innovation and Delivery Center

Trigyn Announces AI Innovation and Delivery Center

Trigyn Announces AI Innovation and Delivery Center

Trigyn Awarded Baltimore County, Maryland Temporary Staffing Contract

Trigyn Awarded Baltimore County, Maryland Temporary Staffing Contract

Trigyn Awarded Baltimore County, Maryland Temporary Staffing Contract

Trigyn Technologies Inc. is a wholly owned subsidiary of Trigyn Technologies Ltd. collectively, we are committed to providing transparent and timely information to all of the stakeholders who have put their trust in us.

For any media-related inquiries, we encourage you to use our “Contact Us” form, available by clicking here.

For information about investment-related topics or stock information, please visit our Investors page by clicking here. For Investor or stock related inquiries, please use the contact information specified on the Investors page.

Thank you for your interest in Trigyn.